We are live on ! Find out more
AI

Advent International Portfolio holdings

AUM $4.24B
1-Year Est. Return 4.24%
This Fund
S&P 500
This Quarter Est. Return
+14.82%
1 Year Est. Return
+4.24%
3 Year Est. Return
+15.25%
5 Year Est. Return
-41.72%
10 Year Est. Return
+104.97%
AUM
$1.3B
AUM Growth
+$1.17B
Cap. Flow
-$636K
Cap. Flow %
-0.05%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AEGR
Aegerion Pharmaceuticals
AEGR
+$636K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 99.3%
2 Healthcare 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LULU icon
1
lululemon athletica
LULU
$13.2B
$1.29B 99.3%
20,105,279
– –
AEGR
2
DELISTED
Aegerion Pharmaceuticals
AEGR
$9.08M 0.7%
347,001
-25,000
-7% -$636K

Similar funds

MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
SLI
Sumitomo Life Insurance Tokyo, Japan $4.25B AUM 23.69% 1-Year Est. Return
CIC
Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Advent International's Q1 2015 Portfolio in Review

As of Q1 2015, Advent International held 2 positions worth $1.3B, up 935% from $125M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2015: portfolio turnover was 0%. Advent International opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 99% of assets, up from 94% a quarter earlier, followed by Healthcare.

  • Advent International's biggest Q1 2015 reduction was Aegerion Pharmaceuticals, cutting an estimated $636K.
  • Advent International's ten largest holdings make up 100% of its $1.3B portfolio in Q1 2015.
  • Advent International opened 0 new positions and closed 0 in Q1 2015.
  • Advent International's portfolio value rose 935% quarter-over-quarter to $1.3B.

Based on Advent International's 13F filing for Q1 2015, filed 17 Apr 2015.